In the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
Others have stated their priorities directly with Federal Government. Through these interviews, AHJ gives a final opportunity to communicate to all health stakeholders, the funding needs for a range of priorities. These range from new models of care to pilots and wholesale, system improvements to building more sustainable workforces to help grow certain sectors of the health system
The CEO of Research Australia, Nadia Levin spoke with Australian Health Journal about the following:
- Current medical research and development landscape in Australia
- Investment required to support the Health and Medical Research and Innovation pipeline
- The National Medical Products Industry Plan and its impact on the Australian economy
And lastly Nadia looks at the challenges of the health and medical research sector. In recent years a survey on early and mid-stage researchers by Research Australia, showed 2 out of every 3 were reconsidering a career in research. The workforce of the future will need to look at the role of the human and medical researcher, knowing innovation does exist and will need to continue to change Australia lives (including an ageing population), and deliver new economies of the future.
-
Analogy of the system, rather than the ED front door
“The problem of blockages shows up in ambulance ramping and long wait times, but this is a complex issue requiring whole-of-health system solutions,” according to Professor Hugh Grantham, Chair of Emergency Medicine Foundation in an interview with Australian Health Journal.
-
GP lens on Aboriginal health and COVID-19
The COVID-19 pandemic rolled through 2020 and the first half of 2021 without major lockdowns in regional communities, however recently that changed. The concern is now on vaccination rates in communities across Australia.
First Nation Aboriginal communities are at greater risk of outbreaks and transmission with low vaccination rates because of supply issues and changing advice rather than hesitancy.
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
